78 related articles for article (PubMed ID: 9463023)
1. [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept].
Selam JL
Diabetes Metab; 1997 Nov; 23 Suppl 4():39-43. PubMed ID: 9463023
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
[TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
4. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
[TBL] [Abstract][Full Text] [Related]
5. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
Jaber LA; Ducharme MP; Halapy H
Ther Drug Monit; 1996 Feb; 18(1):6-13. PubMed ID: 8848822
[TBL] [Abstract][Full Text] [Related]
6. Glipizide: a review of its pharmacological properties and therapeutic use.
Brogden RN; Heel RC; Pakes GE; Speight TM; Avery GS
Drugs; 1979 Nov; 18(5):329-53. PubMed ID: 389600
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of glipizide after once-daily and divided doses.
Kradjan WA; Takeuchi KY; Opheim KE; Wood FC
Pharmacotherapy; 1995; 15(4):465-71. PubMed ID: 7479199
[TBL] [Abstract][Full Text] [Related]
8. Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetes.
Jönsson A; Chan JC; Rydberg T; Vaaler S; Hallengren B; Cockram CS; Critchley JA; Melander A
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):711-4. PubMed ID: 11214781
[TBL] [Abstract][Full Text] [Related]
9. Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus.
Foster RH; Plosker GL
Pharmacoeconomics; 2000 Sep; 18(3):289-306. PubMed ID: 11147395
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.
Harrower AD
Clin Pharmacokinet; 1996 Aug; 31(2):111-9. PubMed ID: 8853933
[TBL] [Abstract][Full Text] [Related]
11. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
Langtry HD; Balfour JA
Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
[TBL] [Abstract][Full Text] [Related]
12. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
Carroll MF; Gutierrez A; Castro M; Tsewang D; Schade DS
J Clin Endocrinol Metab; 2003 Nov; 88(11):5248-54. PubMed ID: 14602757
[TBL] [Abstract][Full Text] [Related]
13. [The discovery of hypoglycemic sulfonamides].
Loubatières-Mariani MM
J Soc Biol; 2007; 201(2):121-5. PubMed ID: 17978743
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.
Courtois P; Sener A; Herbaut C; Turc A; Malaisse WJ
Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):211-22. PubMed ID: 10461687
[TBL] [Abstract][Full Text] [Related]
15. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
Prendergast BD
Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
[TBL] [Abstract][Full Text] [Related]
16. NIDDM in the cat: treatment with the oral hypoglycemic medication, glipizide.
Ford SL
Vet Clin North Am Small Anim Pract; 1995 May; 25(3):599-615. PubMed ID: 7660535
[TBL] [Abstract][Full Text] [Related]
17. [Timing of administration of sulfonyl urea derivatives].
de Smet PA; Fischer HR
Ned Tijdschr Geneeskd; 2000 Jun; 144(25):1206-9. PubMed ID: 10897299
[TBL] [Abstract][Full Text] [Related]
18. The effect of hyperglycemia on glipizide absorption in NIDDM patients.
Esmatjes E; Vinuesa P; Navarro P; Rodriguez-Villar C; Gomis R; Vilardell E
Diabetes Care; 1995 Jul; 18(7):1075-6. PubMed ID: 7555547
[No Abstract] [Full Text] [Related]
19. Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats.
Bennett N; Papich MG; Hoenig M; Fettman MJ; Lappin MR
Am J Vet Res; 2005 Apr; 66(4):581-8. PubMed ID: 15900936
[TBL] [Abstract][Full Text] [Related]
20. Comparative single-dose kinetics and effects of four sulfonylureas in healthy volunteers.
Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
Acta Med Scand; 1980; 208(4):301-7. PubMed ID: 6778079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
